2160 — MicroPort CardioFlow Medtech Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$1.81bn
- HK$224.84m
- CNY336.22m
- 49
- 24
- 11
- 13
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -145 | -398 | -183 | -451 | -464 |
Depreciation | |||||
Non-Cash Items | 18.7 | 249 | 24.4 | 170 | 178 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -30.7 | 15.3 | -47.7 | 20.6 | 5.27 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -143 | -110 | -162 | -183 | -207 |
Capital Expenditures | -48.7 | -58.2 | -108 | -49.1 | -30.5 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -6.97 | 1.8 | -329 | -131 | -566 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -55.7 | -56.4 | -437 | -180 | -596 |
Financing Cash Flow Items | -476 | -2.73 | -3.03 | 1.09 | -0.472 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 263 | 676 | 2,226 | -136 | -25.6 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 58.8 | 503 | 1,599 | -345 | -801 |